Even when tumors are very small.
Today; rates are climbing because of the rising incidence of hepatitis C, a primary cause of primary liver cancers. The liver cancer analysis at John Wayne Cancers Institute will be performed in collaboration with Steven D. Colquhoun, M.D., F.A.C.S., Medical Director, Liver Transplantation at Cedars-Sinai Medical Center, Los Angeles. Hoon described. Hoon continued. If test results show that a patient is not responding to medication, we can change that medication instantly, rather than waiting until something bad happens–like a coronary attack. Hoon concluded.?.. Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new cancer biomarkers A $1 million grant from Abraxis Bioscience, Inc. (more…)